Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis

Objective Systemic sclerosis Impact of Disease (ScleroID) is the first comprehensive patient-reported outcome measure (PROM) specifically developed for systemic sclerosis (SSc). We investigated the performance of ScleroID in patients with diffuse cutaneous SSc (dcSSc), as a prerequisite for its use...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ulf Mueller-Ladner, Marco Matucci-Cerinic, Yannick Allanore, Oliver Distler, Cosimo Bruni, Otylia Kowal-Bielecka, Kim Fligelstone, Roger Hesselstrand, László Czirják, Carina Mihai, Gunnel Sandqvist, Rucsandra Dobrota, Patricia E Carreira, Ana Maria Gherghe, Tore Kvien, Turid Heiberg, Alexandru Garaiman, Mike Oliver Becker, Annelise Roennow, Ann Tyrrell Kennedy, Chris Denton
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMJ Publishing Group 2024-11-01
סדרה:	RMD Open
גישה מקוונת:	https://rmdopen.bmj.com/content/10/4/e004653.full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!